参考文献
［1］ Jones JG. Hepatic glucose and lipid metabolism［J］. Diabetologia, 2016,59(6):1098‑1103. DOI: 10.1007/s00125‑016‑3940‑5.
［2］ Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013‑2018［J］. JAMA, 2021,326(24):2498‑2506. DOI: 10.1001/jama.2021.22208.
［3］ Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China［J］. Lancet Diabetes Endocrinol, 2021,9(6):373‑392. DOI: 10.1016/S2213‑8587(21)00045‑0.
［4］ Wasserman DH, Wang TJ, Brown NJ. The vasculature in prediabetes［J］. Circ Res, 2018,122(8):1135‑1150. DOI: 10.1161/CIRCRESAHA.118.311912.
［5］ Koenen M, Hill MA, Cohen P, et al. Obesity, adipose tissue and vascular dysfunction［J］. Circ Res, 2021,128(7):951‑968. DOI: 10.1161/CIRCRESAHA.121.318093.
［6］ Minami T, Muramatsu M, Kume T. Organ/tissue‑specific vascular endothelial cell heterogeneity in health and disease［J］. Biol Pharm Bull, 2019,42(10):1609‑1619. DOI: 10.1248/bpb.b19‑00531.
［7］ Pries AR, Kuebler WM. Normal endothelium［J］. Handb Exp Pharmacol, 2006,(176 Pt 1):1‑40. DOI: 10.1007/3‑540‑32967‑6_1.
［8］ Gimbrone MA Jr, García‑Cardeña G. Endothelial cell dysfunction and the pathobiology of atherosclerosis［J］. Circ Res, 2016,118(4):620‑636. DOI: 10.1161/CIRCRESAHA.115.306301.
［9］ Krüger‑Genge A, Blocki A, Franke RP, et al. Vascular endothelial cell biology: an update［J］. Int J Mol Sci, 2019,20(18): 4411. DOI: 10.3390/ijms20184411.
［10］ Fuster JJ, Ouchi N, Gokce N, et al. Obesity‑induced changes in adipose tissue microenvironment and their impact on cardiovascular disease［J］. Circ Res, 2016,118(11):1786‑1807. DOI: 10.1161/CIRCRESAHA.115.306885.
［11］ Gealekman O, Guseva N, Hartigan C, et al. Depot‑specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity［J］. Circulation, 2011,123(2):186‑194. DOI: 10.1161/CIRCULATIONAHA.110.970145.
［12］ Herold J, Kalucka J. Angiogenesis in adipose tissue: the interplay between adipose and endothelial cells［J］. Front Physiol, 2020,11:624903. DOI: 10.3389/fphys.2020.624903.
［13］ Sharma M, Boytard L, Hadi T, et al. Enhanced glycolysis and HIF‑1α activation in adipose tissue macrophages sustains local and systemic interleukin‑1β production in obesity［J］. Sci Rep, 2020,10(1):5555. DOI: 10.1038/s41598‑020‑62272‑9.
［14］ Jia G, Sowers JR. Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk［J］. Hypertension, 2014,64(6):1192‑1193. DOI: 10.1161/HYPERTENSIONAHA.114.04348.
［15］ Sowers JR, Habibi J, Jia G, et al. Endothelial sodium channel activation promotes cardiac stiffness and diastolic dysfunction in Western diet fed female mice［J］. Metabolism, 2020,109:154223. DOI: 10.1016/j.metabol.2020.154223.
［16］ Sowers JR, Habibi J, Aroor AR, et al. Epithelial sodium channels in endothelial cells mediate diet‑induced endothelium stiffness and impaired vascular relaxation in obese female mice［J］. Metabolism, 2019,99:57‑66. DOI: 10.1016/j.metabol.2019.153946.
［17］ Ninomiya H, Katakami N, Sato I, et al. Association between subclinical atherosclerosis markers and the level of accumulated advanced glycation end‑products in the skin of patients with diabetes［J］. J Atheroscler Thromb, 2018,25(12):1274‑1284. DOI: 10.5551/jat.44859.
［18］ de la Cruz‑Ares S, Cardelo MP, Gutiérrez‑Mariscal FM, et al. Endothelial dysfunction and advanced glycation end products in patients with newly diagnosed versus established diabetes: from the CORDIOPREV study［J］. Nutrients, 2020,12(1): 238. DOI: 10.3390/nu12010238.
［19］ Xie Z, Wang X, Liu X, et al. Adipose‑derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization［J］. J Am Heart Assoc, 2018,7(5): e007442. DOI: 10.1161/JAHA.117.007442.
［20］ Endemann G, Stanton LW, Madden KS, et al. CD36 is a receptor for oxidized low density lipoprotein［J］. J Biol Chem, 1993,268(16):11811‑11816.
［21］ Abumrad NA, el‑Maghrabi MR, Amri EZ, et al. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long‑chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36［J］. J Biol Chem, 1993,268(24):17665‑17668.
［22］ Coburn CT, Knapp FF Jr, Febbraio M, et al. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice［J］. J Biol Chem, 2000,275(42):32523‑32529. DOI: 10.1074/jbc.M003826200.
［23］ Son NH, Basu D, Samovski D, et al. Endothelial cell CD36 optimizes tissue fatty acid uptake［J］. J Clin Invest, 2018,128(10):4329‑4342. DOI: 10.1172/JCI99315.
［24］ Rekhi UR, Omar M, Alexiou M, et al. Endothelial cell CD36 reduces atherosclerosis and controls systemic metabolism［J］. Front Cardiovasc Med, 2021,8:768481. DOI: 10.3389/fcvm.2021.768481.
［25］ Pepino MY, Kuda O, Samovski D, et al. Structure‑function of CD36 and importance of fatty acid signal transduction in fat metabolism［J］. Annu Rev Nutr, 2014,34:281‑303. DOI: 10.1146/annurev‑nutr‑071812‑161220.
［26］ Coe NR, Smith AJ, Frohnert BI, et al. The fatty acid transport protein (FATP1) is a very long chain acyl‑CoA synthetase［J］. J Biol Chem, 1999,274(51):36300‑36304. DOI: 10.1074/jbc.274.51.36300.
［27］ Hall AM, Smith AJ, Bernlohr DA. Characterization of the Acyl‑CoA synthetase activity of purified murine fatty acid transport protein 1［J］. J Biol Chem, 2003,278(44):43008‑43013. DOI: 10.1074/jbc.M306575200.
［28］ Ibrahim A, Yucel N, Kim B, et al. Local mitochondrial ATP production regulates endothelial fatty acid uptake and transport［J］. Cell Metab, 2020,32(2):309‑319. DOI: 10.1016/j.cmet.2020.05.018.
［29］ Hagberg CE, Falkevall A, Wang X, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake［J］. Nature, 2010,464(7290):917‑921. DOI: 10.1038/nature08945.
［30］ Jang C, Oh SF, Wada S, et al. A branched‑chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance［J］. Nat Med, 2016,22(4):421‑426. DOI: 10.1038/nm.4057.
［31］ Bae H, Hong KY, Lee CK, et al. Angiopoietin‑2‑integrin α5β1 signaling enhances vascular fatty acid transport and prevents ectopic lipid‑induced insulin resistance［J］. Nat Commun, 2020,11(1):2980. DOI: 10.1038/s41467‑020‑16795‑4.
［32］ Iso T, Maeda K, Hanaoka H, et al. Capillary endothelial fatty acid binding proteins 4 and 5 play a critical role in fatty acid uptake in heart and skeletal muscle［J］. Arterioscler Thromb Vasc Biol, 2013,33(11):2549‑2557. DOI: 10.1161/ATVBAHA.113.301588.
［33］ Hwangbo C, Wu J, Papangeli I, et al. Endothelial APLNR regulates tissue fatty acid uptake and is essential for apelin′s glucose‑lowering effects［J］. Sci Transl Med, 2017,9(407)： eaad4000. DOI: 10.1126/scitranslmed.aad4000.
［34］ Jabs M, Rose AJ, Lehmann LH, et al. Inhibition of endothelial notch signaling impairs fatty acid transport and leads to metabolic and vascular remodeling of the adult heart［J］. Circulation, 2018,137(24):2592‑2608. DOI: 10.1161/CIRCULATIONAHA.117.029733.
［35］ Young SG, Fong LG, Beigneux AP, et al. GPIHBP1 and lipoprotein lipase, partners in plasma triglyceride metabolism［J］. Cell Metab, 2019,30(1):51‑65. DOI: 10.1016/j.cmet.2019.05.023.
［36］ Gluchowski NL, Becuwe M, Walther TC, et al. Lipid droplets and liver disease: from basic biology to clinical implications［J］. Nat Rev Gastroenterol Hepatol, 2017,14(6):343‑355. DOI: 10.1038/nrgastro.2017.32.
［37］ Robson A. Blocking endothelial lipase raises HDL‑C levels［J］. Nat Rev Cardiol, 2021,18(7):461. DOI: 10.1038/s41569‑021‑00563‑y.
［38］ Le Lay JE, Du Q, Mehta MB, et al. Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial［J］. Sci Transl Med, 2021,13(590):eabb0602.DOI: 10.1126/scitranslmed.abb0602.
［39］ Thorens B, Mueckler M. Glucose transporters in the 21st Century［J］. Am J Physiol Endocrinol Metab, 2010,298(2):E141‑E145. DOI: 10.1152/ajpendo.00712.2009.
［40］ Totary‑Jain H, Naveh‑Many T, Riahi Y, et al. Calreticulin destabilizes glucose transporter‑1 mRNA in vascular endothelial and smooth muscle cells under high‑glucose conditions［J］. Circ Res, 2005,97(10):1001‑1008. DOI: 10.1161/01.RES.0000189260.46084.e5.
［41］ Vicent D, Ilany J, Kondo T, et al. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance［J］. J Clin Invest, 2003,111(9):1373‑1380. DOI: 10.1172/JCI15211.
［42］ Kubota T, Kubota N, Kumagai H, et al. Impaired insulin signaling in endothelial cells reduces insulin‑induced glucose uptake by skeletal muscle［J］. Cell Metab, 2011,13(3):294‑307. DOI: 10.1016/j.cmet.2011.01.018.
［43］ Akakabe Y, Koide M, Kitamura Y, et al. Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions［J］. Nat Commun, 2013,4:2389. DOI: 10.1038/ncomms3389.
［44］ Azizi PM, Zyla RE, Guan S, et al. Clathrin‑dependent entry and vesicle‑mediated exocytosis define insulin transcytosis across microvascular endothelial cells［J］. Mol Biol Cell, 2015,26(4):740‑750. DOI: 10.1091/mbc.E14‑08‑1307.
［45］ Wang H, Wang AX, Aylor K, et al. Nitric oxide directly promotes vascular endothelial insulin transport［J］. Diabetes, 2013,62(12):4030‑4042. DOI: 10.2337/db13‑0627.
［46］ Das A, Huang GX, Bonkowski MS, et al. Impairment of an endothelial NAD+‑H2S signaling network is a reversible cause of vascular aging［J］. Cell, 2018,173(1):74‑89.e20. DOI: 10.1016/j.cell.2018.02.008.
［47］ Calissi G, Lam EW, Link W. Therapeutic strategies targeting FOXO transcription factors［J］. Nat Rev Drug Discov, 2021,20(1):21‑38. DOI: 10.1038/s41573‑020‑0088‑2.
［48］ Nwadozi E, Roudier E, Rullman E, et al. Endothelial FoxO proteins impair insulin sensitivity and restrain muscle angiogenesis in response to a high‑fat diet［J］. FASEB J, 2016,30(9):3039‑3052. DOI: 10.1096/fj.201600245R.
［49］ Watt NT, Gage MC, Patel PA, et al. Endothelial SHIP2 suppresses Nox2 NADPH oxidase‑dependent vascular oxidative stress, endothelial dysfunction, and systemic insulin resistance［J］. Diabetes, 2017,66(11):2808‑2821. DOI: 10.2337/db17‑0062.
［50］ Tsuchiya K, Accili D. Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance［J］. Diabetes, 2013,62(5):1478‑1489. DOI: 10.2337/db12‑1296.
［51］ Monelli E, Villacampa P, Zabala‑Letona A, et al. Angiocrine polyamine production regulates adiposity［J］. Nat Metab, 2022,4(3):327‑343. DOI: 10.1038/s42255‑022‑00544‑6.
［52］ Liao CY, Kummert O, Bair AM, et al. The autophagy inducer spermidine protects against metabolic dysfunction during overnutrition［J］. J Gerontol A Biol Sci Med Sci, 2021,76(10):1714‑1725. DOI: 10.1093/gerona/glab145.
［53］ Tran KV, Gealekman O, Frontini A, et al. The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells［J］. Cell Metab, 2012,15(2):222‑229. DOI: 10.1016/j.cmet.2012.01.008.
［54］ Seki T, Hosaka K, Lim S, et al. Endothelial PDGF‑CC regulates angiogenesis‑dependent thermogenesis in beige fat［J］. Nat Commun, 2016,7:12152. DOI: 10.1038/ncomms12152.
［55］ Seki T, Hosaka K, Fischer C, et al. Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning［J］. J Exp Med, 2018,215(2):611‑626. DOI: 10.1084/jem.20171012.
［56］ Tang X, Miao Y, Luo Y, et al. Suppression of endothelial AGO1 promotes adipose tissue browning and improves metabolic dysfunction［J］. Circulation, 2020,142(4):365‑379. DOI: 10.1161/CIRCULATIONAHA.119.041231.
